Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

BACKGROUND: Discontinuation of rheumatoid arthritis (RA) treatment for lack or loss of initial response, tolerability issues, or development of antibodies against the therapeutic agent remains a challenge in clinical practice. Here we present a 6-month interim analysis of a 2-year prospective observ...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Nüßlein, Hubert G, Alten, Rieke, Galeazzi, Mauro, Lorenz, Hanns-Martin, Boumpas, Dimitrios, Nurmohamed, Michael T, Bensen, William G, Burmester, Gerd R, Peter, Hans-Hartmut, Rainer, Franz, Pavelka, Karel, Chartier, Melanie, Poncet, Coralie, Rauch, Christiane, Bars, Manuela Le
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898027/
https://ncbi.nlm.nih.gov/pubmed/24410774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2474-15-14
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia